© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Ethacridine lactate, known to many in the medical field since the early 20th century, arrived at a time when infectious diseases often claimed lives due to a lack of effective antiseptics. German chemists brought this compound to clinical practice, offering a bright yellow solution that stood out on wound dressings before antibiotics reigned. In war zones and poverty-stricken clinics, this substance delivered hope, helping doctors clean wounds and prevent sepsis long before penicillin found its footing. Over the decades, as health care advanced, standards for medical-grade antiseptics climbed, and yet, ethacridine lactate managed to retain its place in many formularies, a testament to its reliability and value in fighting microbes.
Ethacridine lactate’s reputation comes from its activity as a local antiseptic and disinfectant. As a monohydrate, its molecular structure C18H21N3O4·C3H6O3·H2O confers stability and easy solubility in water, giving clinicians flexibility across liquid applications. I have seen this compound in both over-the-counter wound cleansers and hospital-grade irrigation fluids. The unmistakable yellow tint helps caregivers visually confirm application, and its very presence in many countries’ essential drug lists signals enduring trust in its local anti-infective capabilities.
Physically, ethacridine lactate monohydrate appears as a bright yellow, crystalline powder with a faint, not unpleasant odor that signals chemical purity. Solubility in cold water exceeds 1%, which makes it simple for pharmacy staff to prepare topical solutions, even in basic settings with limited equipment. Melting points hover around 200° Celsius (dec.), ensuring stability during storage in most climates. Chemically, the compound’s acridine backbone supports a range of chemical modifications, but the lactate salt keeps it less irritating to human tissues than other acridines, lowering risks during actual patient use.
Packages of ethacridine lactate monohydrate should carry clear batch numbers, manufacturing dates, and active ingredient percentages. In regulated markets, a pharmacopeia standard—such as compliance with the European or United States Pharmacopeia—guarantees that what’s on the label will perform as expected clinically. Staff pharmacists rely on these details to ensure both efficacy and patient safety, and inspectors in many parts of the world routinely pull samples to test compliance.
Large-scale synthesis often begins with acridine, which undergoes nitration before reduction and subsequent reaction with ethyl chloroacetate. Secondary reactions convert the intermediate to ethacridine, and finally, lactate forms the salt during crystallization. In practical pharmacy settings, this final salt reaches its intended aqueous solution through simple dissolution in sterile water, a job that involves little more than gentle agitation. These steps avoid complicated equipment, which opens the door to wide geographical distribution.
The acridine nucleus in ethacridine supports further chemical tweaking. Over the years, researchers have extended its utility through methylation, acylation, and even halogenation, seeking greater antimicrobial potency or different pharmacological profiles. Meanwhile, the lactate salt endures as the safest, easiest-to-use variant, and no transition to alternative salts has outperformed its tissue compatibility. Even so, synthetic chemists keep probing for versions with broader spectra or reduced development of bacterial resistance.
Ethacridine lactate hides behind many aliases in pharmacopoeias and formularies. Often turned up as Rivanal, Acrinol, and Rivanol, the compound travels worldwide under slightly altered spellings. Hospital pharmacists and emergency staff sometimes refer to it simply by its color or function, such as “yellow antiseptic” or “acridine solution.” Seeing so many synonyms in practice—especially in multilingual environments—underscores the importance of chemical codes like CAS numbers for tracking safety data and product recalls.
Safety remains a cornerstone in any topical medication, and ethacridine lactate holds its place through a strong side effect profile. Most reported reactions remain mild: brief stinging, minor local irritation, and an occasional rash. Staff in neonatal or burn units lean on this record, preferring it over harsh oxidizers like iodine. Occupational safety standards, including guidelines for solution preparation and skin exposure, help reduce workplace incidents. Its sharp yellow dye can stain skin and textiles for several days, but clinicians see this as a minor tradeoff, not a dealbreaker. Waste handling calls for normal biological protocols, with most authorities allowing routine sewer disposal of diluted solutions.
Ethacridine lactate gets most of its use in superficial wound irrigation, surgical field cleansing, and as a standby for minor dermatological infections. Surgical teams trust it for abdominal washing in certain gynecological interventions. In some countries, it also has a role in second-trimester abortion protocols due to its uterotonic effect when administered intra-amniotically. The wide spectrum—covering Gram-positive bacteria, some Gram-negatives, and even anaerobes in laboratory tests—means it finds regular use across sports clinics, battlefield medicine, and rural outpatient facilities alike. I have personally watched rural health workers depend on it as a safe fallback when access to new-generation agents breaks down or gets delayed.
Academic and industrial labs have not abandoned ethacridine lactate. Researchers monitor for emerging resistance and tweak formulations to deliver greater comfort and faster healing. Interest in new delivery systems—hydrogels, sustained-release films, dual-antiseptic mixtures—keeps the compound relevant. Peer-reviewed studies in microbiology journals often cite its effectiveness compared with other late-stage alternatives, especially where cost shaping decisions matter more than brand recognition or patent status. Scientists and clinicians gather at conferences to compare infection rates and side effect profiles, ensuring the next updates in surgical practice draw on both tradition and new evidence.
Toxicologists watch for systemic absorption, but the molecule’s size and solubility mostly corral it to the surface layers of skin and mucosa. Animal studies conducted in the last century reported high safety margins and rare cases of systemic toxicity except in gross overdose. Modern adverse event tracking continues to show a reassuring picture, with real dangers limited to allergy-prone individuals or improper administration, such as accidental injection. In my experience, routine monitoring and patient education cut risk lower still, as trained staff spot and respond to any hypersensitivity almost on autopilot.
The rise of antibiotic resistance and global efforts to reduce unnecessary antibiotic use point back to time-tested solutions like ethacridine lactate. While the pharma world races for new molecules, this compound’s cost profile gives it a key role in developing countries, disaster response packs, even basic first aid kits worldwide. Companies investigate tweaks for improved shelf stability and broader shelf-life, which could expand storage options in harsh climates. Future prospects look good for a compound that delivers measurable protection from wound infection, leaves resistance worries in the shade, and carries a safety record that most new drugs only dream of matching.
Ask an experienced nurse in any hospital about that bright yellow antiseptic, and many will point straight to ethacridine lactate. This compound cleans wounds and keeps bacteria at bay. I’ve seen health workers splash it on scrapes, burns, or surgical sites right before bandaging. In a world full of antibiotics and high-tech ointments, this straightforward solution still holds a spot on hospital carts, especially where budgets stay tight.
Ethacridine lactate has been around for nearly a century. Back in the early days, medical staff didn’t have the luxury of wide-ranging antibiotics. They relied on careful cleaning to keep infections from taking hold. Even now, this preparation carries value in facilities where resources don’t stretch to newer, more expensive options.
It works by disrupting cell walls and halting the growth of common bacteria. That’s not just a laboratory claim — studies have supported its action against both Staphylococcus aureus and Streptococcus. During my own clinical placements, surgeons would reach for ethacridine especially on minor wounds, ulcers, and even for washing hands before gloving up.
You won’t find it front and center in every pharmacy. In most North American and Western European settings, doctors choose povidone-iodine or chlorhexidine. In India, Southeast Asia, Eastern Europe, and parts of Africa, ethacridine continues to help fight infection. Its cost stays low. It doesn’t sting or stain skin badly. More importantly, it sidesteps the risk of allergic reactions tied to iodine or alcohol-based cleansers.
There's another use health professionals don’t talk about much: ethacridine lactate has a place in obstetrics, especially in countries where safe, legal abortion remains restricted. Some doctors have injected it into the uterus in the second trimester to induce labor. Big organizations and the World Health Organization have moved toward safer, more reliable medications for this task, citing better outcomes and fewer side effects. Still, its past use speaks to the way clinicians repurposed available drugs under tough circumstances.
Reading up on ethacridine, I’ve seen plenty of folk medicine and Internet myth. People sometimes mistake “mild antiseptic” for “gentle enough to swallow” or even “cure for all sorts of problems.” Ingesting it causes nausea, vomiting, and can damage tissues. There’s a reason trained staff reserve it for external wounds and careful procedures.
One thing patients often overlook: resistance doesn’t grow against this compound the way it can with antibiotic creams. This means clinics can use it for dressing changes in chronic ulcers, diabetic wounds, and burns without fueling the rise of superbugs.
More advanced countries sometimes dismiss older compounds as outdated, but every tool has a place. Hospitals facing shortages, clinics far from urban centers, and humanitarian aid workers pack ethacridine lactate for its reliability. Cuts, grazes, and even surgical fields get cleaner faster, infections fall, and outcomes improve.
If policymakers want better infection control in lower-income settings, supporting the supply of effective, affordable antiseptics matters as much as rolling out new drugs. Investing a little effort in simple, science-backed measures saves lives — and sometimes the oldest bottle on the shelf still does the trick.
A lot of hospital cabinets keep both ethacridine lactate and ethacridine lactate monohydrate tucked away on the shelves. Both fight off infection in wounds and help clean skin. Still, there’s a real need to know why these two are labeled differently and why that matters to those working hands-on in care.
Ethacridine lactate stands as a straight-up salt formed from ethacridine and lactic acid. The monohydrate version, though, comes with a single water molecule attached. At first glance the names look almost identical, but that extra water molecule in the monohydrate really means something for those who weigh, mix, or prescribe these drugs.
Anyone who has ever measured chemicals or weighed out ingredients knows small differences in shape or amount can have an impact. For these drugs, the “water” in the monohydrate changes how much active medicine lands in each dose. For every gram of ethacridine lactate monohydrate, the real dose of medicine ends up a little lower compared to the plain salt form, thanks to the weight of that water. The result: If you want to match the punch of the plain salt, you’ll need just a bit more of the monohydrate version.
I spent years working close to nurses and doctors who prepare dressings for wounds and mix up disinfecting solutions. Nobody wants mistakes on dose. Using too little means the drug won’t clear up infection. Too much brings risks of side effects or, in rare cases, irritation to tissue. Getting this difference right becomes critical.
A review in the Journal of Hospital Pharmacy points out dosing slip-ups happen most where labels aren’t clear, or staff swap one version for the other without recalculating. That’s not just some technical detail; real people suffer or heal based on details like this. There have been reported errors in both directions—sometimes folks give a tad less medicine, sometimes a touch more. Both spell potential trouble.
Some might shrug off the chemical side and focus on just the healing. But skipping those details shortchanges both the patient and the system. You want full value from infection fighting, but zero surprises from dosing. In my own family, we keep a standard kit for cuts and scrapes. A talk with a pharmacist made it clear—make sure you ask specifically which version sits in your box. A quick check of the label and a search for “monohydrate” found us the right one, and the dosing advice matched what was needed.
The literature supports clear labeling and simple charts in hospitals. There have even been calls for supply chains to standardize their forms, or at the very least, flag the differences right in bold type on the packaging. Good pharmacy software also tracks these differences now, but education still counts the most—front-line staff need to double-check before they reach for the bottle.
The answer isn’t waiting for regulators. Any clinic or family pharmacy benefits from a basic routine: always check if the label says “monohydrate”, and adjust the weight or volume as advised by the official references or the pharmacist. Investing a minute to confirm pays off with safe treatment, and that goes a long way in keeping wounds clean and healing smooth.
Ethacridine lactate landed on my radar when a pharmacist friend spoke to me about patients who struggle with keeping their medicine safe and effective. This compound, widely used for its antiseptic properties, always packs a punch in hospitals and clinics when it’s time to prevent infections. But what many people overlook is that the real fight against contamination often starts at home, sometimes before it even hits the wound.
People store medications on sunny windowsills, inside humid bathrooms, and sometimes thrown into car glove compartments—habits shaped by convenience, not caution. Yet, the chemistry behind ethacridine lactate is straightforward: exposure to heat, light, and moisture shortens its shelf life and reduces effectiveness. I’ve seen bottles practically change color when left out in direct sunlight. That’s not just a cosmetic issue. It means the drug breaks down, and what ends up on your skin might simply not protect you the way a pharmacist expects.
The best place for ethacridine lactate sits in a cool, dry cabinet, away from sunlight. That’s what pharmacists recommend for a reason. Storage below 25°C slows the breakdown process—simple, science-backed advice anyone can trust. If your home feels like a sauna, a kitchen drawer far from the stove beats the medicine cabinet in a bathroom that steams up with every shower. Manufacturers provide advice for a reason, and most package inserts echo this point to anyone who cares to read them.
In practice, not everyone reads those inserts, and too many folks toss out the original packaging. My own parents used to cut corners—taking blister packs out of boxes to save space. Quick tip: keeping medicine in its original box helps. The packaging works as a shield against accidental exposure to light and moisture, and the printed storage guides stay right where you need them. Heavy humidity can sneak through cardboard, but any barrier slows down the damage. Simple vigilance—checking the box every time you reach for it—could spare you from using a product that’s turned cloudy, or worse, lost its antiseptic punch.
Keepsake stories about kids swallowing what they shouldn’t come up too often among parents. Locking away ethacridine lactate matters. It comes in bright yellow, catches the eye, especially of young children or even pets. Hospitals know this all too well; robust, childproof caps and clear warning labels are not just for show. Home storage should follow this logic by using high shelves or child-locked cupboards. The effort to keep medications out of reach buys peace of mind that no accident is waiting around the corner.
Every home has its blind spots. Some people don’t label bottles once opened, or they leave cap threads wet, leading to crust around the lid, which can introduce contaminants. After each use, screwing the cap tightly back on and giving it a quick wipe doesn’t just keep things tidy—it helps protect the solution. Checking the expiration date every couple of months takes seconds and saves a lot of trouble. Bringing expired or suspicious bottles back to the pharmacy for safe disposal stops confusion, keeps your house safer, and helps the environment avoid chemical pollution.
I’ve witnessed firsthand how proper storage pays off. Neighbors whose dogs once chewed into a bottle now keep all their first aid supplies on a high kitchen shelf, well out of reach. My friend in healthcare tells me stories of nearly empty bottles tucked deep in someone’s bag—months or years past use. A culture of reading labels, respecting basic guidelines, and removing old chemicals can change the story. Patient safety can’t be separated from the day-to-day routines at home.
Ethacridine lactate has a long history in medicine, often showing up in hospitals and clinics as an antiseptic. Doctors sometimes use it in wound cleaning or for certain gynecological procedures. It’s known for its deep yellow color and strong antimicrobial punch, keeping bacteria at bay. The fact that it has stuck around for decades says something about its usefulness, but, like any tool in the medical bag, it comes with some drawbacks.
Every treatment has its trade-offs. With ethacridine lactate, the most common side effects relate to skin and tissue reactions. Patients usually notice local irritation, redness, or mild swelling after use. Sometimes, direct contact can result in a burning or stinging feeling, which fades after rinsing or stopping the application.
The skin sometimes rebels with a rash. Anyone with a history of allergies or sensitive skin feels these effects more often. Repeated use can dry out the skin at the site, leaving it flaky or itchy. These side effects often signal that it’s time to check in with a doctor, especially if symptoms don’t settle quickly.
It’s rare, but some folks develop a more serious reaction. Allergic responses can include hives, swelling, or difficulty breathing. Reports exist of anaphylaxis, a medical emergency, from even small doses, though this doesn’t happen often. It pays to know your allergy history and watch for warning signs during use. Being prepared beats getting caught off guard.
In medical procedures, such as those involving the uterus, ethacridine lactate sometimes triggers cramping, increased bleeding, or infection. Doctors keep a close eye on patients for these reasons. These risks highlight how important it is for professionals to weigh the benefits and drawbacks before choosing this medication.
Several studies back up what doctors already see in practice. Research in peer-reviewed journals like the Journal of Hospital Infection lists skin and mucosal irritation as the most reported side effects. The World Health Organization notes that allergic reactions are infrequent, but they do get documented. A meta-analysis on obstetric use published in Obstetrics & Gynecology links higher rates of local pain and mild infection compared to less irritating alternatives.
Even though side effects usually don’t last, long-term use over large skin areas can raise the chances of problems. In my time volunteering at clinics, I watched nurses deal with stubborn rashes or lingering discomfort in patients who used ethacridine for extended periods. Their frustration was clear: a strong antiseptic shouldn’t bring more trouble than it solves.
Using ethacridine lactate safely requires careful attention. Doctors advise starting with small patches, especially with a history of skin allergies. Medical teams often keep steroid creams or antihistamines ready in case of an unexpected rash. Patients should definitely let their care team know about any previous reactions to antiseptics or dyes.
For routine wound care, clinicians keep the drug away from large open wounds and mucous membranes. Washing the solution off thoroughly helps cut down on irritation. In healthcare settings, sticking to good protocols can lower the odds of side effects turning into bigger problems. It also pays to keep patients informed so they can spot early signs of trouble at home—because nothing replaces fast, informed action when something feels off.
Ethacridine lactate usually shows up in antiseptic solutions, especially for wound cleaning. In some countries, doctors have used it to help induce abortion during the second trimester. The big question many women and families face is whether exposure to this compound poses risks during pregnancy or breastfeeding. People tend to get uneasy when a medicine has even a remote history tied to pregnancy complications, and it makes sense to want to know who can safely use it and who should avoid it.
Doctors rarely prescribe ethacridine lactate even as an abortive agent anymore. Other drugs like misoprostol and mifepristone have replaced it in most places because of their stronger records for predictability and safety. Evidence from studies dating back to the 1960s and 1970s show that ethacridine lactate absorbed through the uterus does get into the bloodstream, sometimes causing irritation, infection, or unexpected effects on the mother. Some case reports describe infection and retained products after use. Women exposed vaginally or through the cervix during medical procedures reported more complications than those undergoing more modern methods.
Even topical use of ethacridine lactate—like using it to clean wounds—raises concerns in pregnancy. Direct absorption through broken skin is possible, and safety data in pregnant people are scarce. The World Health Organization does not recognize it as a recommended medicine for infection control in newborns or in pregnancy.
Scientists do not have enough quality evidence describing whether ethacridine lactate passes into breast milk in significant quantities. Based on how the body processes the compound, only tiny amounts—if any—should reach the bloodstream after topical use. So far, no human studies have published reports of infants harmed by this antiseptic when their mothers used it on their skin. At the same time, because babies have skin that absorbs chemicals more easily and kidneys that filter medicines more slowly, many hospitals avoid exposing breastfeeding mothers and their newborns to any unnecessary medicinal chemicals.
Throughout my career in pharmacy, caregivers and parents often ask whether a certain over-the-counter lotion, disinfectant, or ointment is safe around infants. Without solid science to clear something with confidence, most medical professionals look for cleaner alternatives with decades of proven history—simple soap, plain water, or well-established antiseptics.
Pregnancy already comes with a mental load of navigating what’s safe and what could possibly cause harm. Many women learn the hard way that regulatory agencies update advice only when enough real-life cases build up, often after the fact. Even trusted reference guides for medication in pregnancy include a caution flag for ethacridine lactate, reflecting a lack of reassuring safety data.
Healthcare providers juggle the risks of infection against the risks of exposing both mothers and babies to a medicine not fully vetted for sensitive groups. With modern antiseptics widely available and safe when used as directed, most hospitals steer clear of ethacridine lactate in pregnancy and lactation altogether.
Every expecting or breastfeeding mother values peace of mind. When someone asks about products for wound care or antisepsis, the safest approach leans toward using products with rock-solid safety records. Asking the obstetrician or pediatrician makes a lot of sense. When in doubt, less is more—especially around new babies. Looking for validated choices, along with careful reading of product labels, helps families avoid taking unnecessary risks. The advances in medicine over the past fifty years exist to give today's families better, more reliable options than they had in the past.
| Names | |
| Preferred IUPAC name | 2-ethoxy-6,9-diaminoacridin-10-ium lactate monohydrate |
| Other names |
Acrinol Lactate Ethacridini lactas Rivanol Rivanolum 6,9-Acridinediamine, N-ethoxy-, lactate (1:1) Ethacridinum lacticum Ethacridine lactic acid |
| Pronunciation | /ɪˈθækrɪdiːn ˈlækteɪt/ |
| Identifiers | |
| CAS Number | 6402-23-9 |
| Beilstein Reference | 3561372 |
| ChEBI | CHEBI:5947 |
| ChEMBL | CHEMBL2104720 |
| ChemSpider | 23864306 |
| DrugBank | DB00702 |
| ECHA InfoCard | 03b9bc89-3886-4103-8ef2-2e271e26b046 |
| EC Number | 222-568-5 |
| Gmelin Reference | 141495 |
| KEGG | C07346 |
| MeSH | D004976 |
| PubChem CID | 73462 |
| RTECS number | SF7175000 |
| UNII | Y10P4J7M5Z |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C18H21N3O4·C3H6O3·H2O |
| Molar mass | 545.55 g/mol |
| Appearance | Yellow crystalline powder |
| Odor | Odorless |
| Density | 1.37 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -1.7 |
| Acidity (pKa) | 7.32 |
| Basicity (pKb) | 12.65 |
| Magnetic susceptibility (χ) | -81.0×10^-6 cm³/mol |
| Dipole moment | 5.5 D (Ethacridine lactate monohydrate) |
| Thermochemistry | |
| Std molar entropy (S⦵298) | “Ethacridine Lactate: 665.8 J·mol⁻¹·K⁻¹; Ethacridine Lactate Monohydrate: 735.1 J·mol⁻¹·K⁻¹” |
| Pharmacology | |
| ATC code | D08AJ02 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. Causes skin irritation. May cause respiratory irritation. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302, H319 |
| Precautionary statements | Precautionary statements: P264, P273, P280, P305+P351+P338, P337+P313 |
| Explosive limits | Not explosive |
| Lethal dose or concentration | LD50 (oral, rat): 700 mg/kg |
| LD50 (median dose) | LD50 (median dose): Mouse oral 2 g/kg |
| NIOSH | MX8400000 |
| PEL (Permissible) | PEL: Not established |
| REL (Recommended) | 0.1% |
| Related compounds | |
| Related compounds |
Acridine Ethidium bromide Proflavine Aminacrine Flavin mononucleotide |
